Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : NSC23925
CAS No.: 858474-14-3
Catalog No.: PC-62665Not For Human Use, Lab Use Only.
NSC 23925 is a small molecule compound that reverses multiple drug resistance (MDR) in human cancer cell lines, reverses MDR1 (Pgp1) but does not inhibit MRP or BCRP-mediated MDR.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $98 | In stock | |
| 10 mg | $158 | In stock | |
| 25 mg | $278 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NSC23925 is a small molecule compound that reverses multiple drug resistance (MDR) in human cancer cell lines, reverses MDR1 (Pgp1) but does not inhibit MRP or BCRP-mediated MDR.
NSC23925 shows maximal reversal of resistance in SKOV-3TR or OVCAR8TR to cytotoxic drugs is 0.5 uM to 1 uM.
NSC23925 stimulates ATPase activity of Pgp, increases the intracellular accumulation of Pgp1 substrates.
| M.Wt | 421.36 | |
| Formula | C22H26Cl2N2O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
2-(p-Methoxyphenyl)-α-2-piperidyl-4-quinolinemethanol dihydrochloride |
|
1. Duan Z, et al. PLoS One. 2009 Oct 12;4(10):e7415.
2. Duan Z, et al. J Med Chem. 2012 Apr 12;55(7):3113-21.
3. Yang X, et al. Br J Cancer. 2014 Jun 10;110(12):2896-904.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
